ArticlePain reports2025
Biotinidase as a novel biomarker for pain assessment in dairy cattle.
Article in Pain reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Freedom from pain is a key component of animal welfare. However, unlike in humans, objective methods for assessing and managing pain in farm animals remain limited. Pain assessment is particularly challenging in cattle, due to their inherently stoic nature. Objective: We investigated biotinidase, an enzyme with amino-exopeptidase activity on opioid neuropeptides, as a novel, short-term pain-biomarker in dairy cattle, in comparison with cortisol and substance P. Methods: Plasma levels of biotinidase, substance P, and cortisol were quantified by ELISA in Holstein cows subjected to 3 distinct pain stimuli: freeze branding (routine husbandry), topical application of capsaicin cream (nonclinical pain model), and spontaneous clinical mastitis. Results: Biotinidase levels increased significantly within 30 minutes after freeze branding compared to controls (1.36 difference of normalized values; Conclusion: These findings provide compelling new evidence that plasma biotinidase responds robustly to diverse pain stimuli in nonhuman mammals. Further studies should investigate its diagnostic performance individually, and alongside other biochemical, physiological, and behavioral indicators, to enhance pain assessment accuracy and of noninvasive pain detection protocols for farm animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.